Pro zobrazení tohoto obsahu je třeba být přihlášen.
Categories for Uncategorized
Adding Ribociclib to First-Line Endocrine Therapy Significantly Improves Survival for Pre-Menopausal Women with Advanced Breast Cancer
19 srpna, 2020 12:54 pmJune 1, 2019 “Advanced breast cancer in pre-menopausal women can be very aggressive. It is important and encouraging to...
Novinky z výročního zasedání ASCO® 2019 v léčbě karcinomu prsu
19 srpna, 2020 12:54 pmLetošní Annual Meeting ASCO® 2019 nepřinesl v léčbě karcinomu žádné převratné výsledky. Je důležité zdůraznit, že mravenčí prací jednotlivých výzkumných týmů...
BRIGATINIB IN PRETREATED PATIENTS WITH ALK-POSITIVE ADVANCED NSCLC
19 srpna, 2020 12:54 pmMeeting 2019 ASCO® Annual Meeting Category Lung Cancer – Non-Small Cell Metastatic Type Poster Session (Monday, June 2,...
PRELIMINARY RESULTS OF SINGLE ARM PHASE 2 TRIAL OF BRIGATINIB IN PATIENTS (PTS) WITH PROGRESSION DISEASE (PD) AFTER NEXT-GENERATION (NG) ANAPLASTIC LYMPHOMA KINASE (ALK) TYROSINE KINASE INHIBITORS (TKIS) IN ALK + NON-SMALL CELL LUNG CANCER (NSCLC)
19 srpna, 2020 12:54 pmMeeting 2019 ASCO® Annual Meeting Category Lung Cancer – Non-Small Cell Metastatic Type Poster Session (Monday, June 2,...
CLINICAL ACTIVITY AND TOLERABILITY OF BLU-667, A HIGHLY POTENT AND SELECTIVE RET INHIBITOR, IN PATIENTS (PTS) WITH ADVANCED RET-FUSION+ NON-SMALL CELL LUNG CANCER (NSCLC)
19 srpna, 2020 12:54 pmMeeting 2019 ASCO® Annual Meeting Category Lung Cancer – Non-Small Cell Metastatic Type Oral Abstract Session (Monday, June...
CAPMATINIB (INC280) IN METΔEX14-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): EFFICACY DATA FROM THE PHASE II GEOMETRY MONO-1 STUDY
19 srpna, 2020 12:54 pmMeeting 2019 ASCO® Annual Meeting Category Lung Cancer – Non-Small Cell Metastatic Type Oral Abstract Session (Monday, June...
Pembrolizumab Increases Historic Survival Rate for Certain People with Advanced Non-Small Cell Lung Cancer
19 srpna, 2020 12:54 pmJune 1, 2019 “These data are similar to what we have seen in other cancers treated with immunotherapy in...
Novinky z letošního setkání ASCO® – karcinom plic
19 srpna, 2020 12:54 pmHlavní přednášková sekce o přístupech k metastazujícím plicním nádorům byla letos zaměřena zejména na molekulárně cílenou léčbu. Bylo prezentováno, že kombinace erlotinibu s ramucirumabem...
ANALYSIS OF SYMPTOMS AND FUNCTIONAL HRQOL SCALES IN TAGS, A PHASE III TRIAL OF TRIFLURIDINE/TIPIRACIL (FTD/TPI) IN METASTATIC GASTRIC CANCER (MGC)
19 srpna, 2020 12:54 pmMeeting 2019 ASCO® Annual Meeting Category Gastrointestinal (Noncolorectal) Cancer / Esophageal or Gastric Cancer Type Poster Session (Monday,...
TRIFLURIDINE/TIPIRACIL (FTD/TPI) IN PATIENTS (PTS) WITH METASTATIC GASTROESOPHAGEAL JUNCTION CANCER (MGEJC): SUBGROUP ANALYSIS FROM TAGS
19 srpna, 2020 12:54 pmMeeting 2019 ASCO® Annual Meeting Category Gastrointestinal (Noncolorectal) Cancer / Esophageal or Gastric Cancer Type Poster Session (Monday,...